Catalyst Event
Boston Scientific Corp (BSX) · Earnings Release
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
7/29/2026, 12:00:00 AM
The Q2 2026 earnings release scheduled for 2026-07-29, for which high importance is estimated due to typical market volatility surrounding quarterly results, is expected.
Korean Translation
2026년 7월 29일로 예정된 2026년 2분기 실적 발표는 통상적으로 높은 변동성을 수반하므로 중요도를 'High'로 예상하며, 해당 일자에 실적 발표가 예정됨.
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
Q2 2026 earnings release and conference call. Medium importance is estimated as earnings releases typically cause >5% price volatility scheduled.
8/5/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q2 2026 earnings release is scheduled for July 16, 2026; a price impact of at least 5% is estimated based on historical volatility, scheduled.
7/16/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Final dividend of HKD 0.20 per share ex-dividend on July 3, 2026; standard corporate action with minor price adjustment scheduled.
7/3/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Other
Ex-dividend date for the 2025 final dividend of HK$0.15 per share, which was announced on March 25, 2026. The payment date is July 15, 2026.
6/24/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Ex-dividend date (2026-06-19) for a proposed record-high annual dividend of CHF 4.70 per share; impact estimated at ~2% as dividend is record-high, scheduled.
6/19/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Annual General Meeting (2026-06-16) where shareholders will vote on proposals including the dividend; impact estimated at ~1% as it is a significant governance event, scheduled.
6/16/2026, 12:00:00 AM